| PD-L1 expression harmonization in gastric cancer using 22C3 PharmDx and SP263 assays TZ Dabbagh, MA Sughayer Applied Immunohistochemistry & Molecular Morphology 29 (6), 462-466, 2021 | 10 | 2021 |
| Expression of PD-L1 using SP142 CDx in triple negative breast cancer GN Al-Jussani, TZ Dabbagh, D Al-Rimawi, MA Sughayer Annals of diagnostic pathology 51, 151703, 2021 | 10 | 2021 |
| PD-L1 expression is a favorable prognostic marker in gastric carcinoma MA Sughayer, TZ Dabbagh, AH Battah Applied Immunohistochemistry & Molecular Morphology 28 (10), 748-754, 2020 | 10 | 2020 |
| The clinicopathological features of programmed death ligand-1 expression in colorectal carcinoma GN Al-Jussani, A Alsughayer, MS Yousuf, Y Mullahuwash, T Dabbagh, ... The International Journal of Biological Markers 37 (3), 322-327, 2022 | 7 | 2022 |
| Changing trends in estrogen receptors/progesterone receptors/human epidermal growth factor receptor 2 prevalence rates among Jordanian patients with breast cancer over the years AM Alsughayer, TZ Dabbagh, RH Abdel-Razeq, GN Al-Jussani, ... JCO global oncology 8, e2100359, 2022 | 3 | 2022 |
| The Value of Virtual Meetings during COVID-19 Pandemic in Healthcare Settings MA Sughayer, TZ Dabbagh, L Souan, A Alsughayer American Journal of Clinical Pathology 158 (Supplement_1), S127-S127, 2022 | | 2022 |
| Changing trends in hormone receptor and Her2 rates in breast cancer overtime M Sughayer, H Abdel-Razeq, G Al-Jussania, A Alsughayer, T Dabbagh, ... VIRCHOWS ARCHIV 479 (SUPPL 1), S73-S74, 2021 | | 2021 |
| Blood Inventory Management at King Hussein Cancer Center Blood Bank. S Bohisi, M Sughayer, T Dabbagh, E Al-Khateeb, A Ataallah, MN Ghanem 2018 Annual Meeting, 2018 | | 2018 |
| Published Ahead-of-Print-Last Updated: January 20, 2021 TZ Dabbagh, MA Sughayer | | |
| Published Ahead-of-Print-Last Updated: February 09, 2021 TZ Dabbagh, MA Sughayer | | |
